Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Egypt flag Egypt · Delayed Price · Currency is EGP
2.000
+0.180 (9.89%)
At close: Jul 7, 2025
Market Cap 455.00M
Revenue (ttm) 22.78M
Net Income (ttm) -18.04M
Shares Out 250.00M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 11,463,590
Average Volume 4,022,441
Open 1.820
Previous Close 1.820
Day's Range 1.770 - 2.090
52-Week Range 0.620 - 2.000
Beta 0.75
RSI 66.00
Earnings Date May 29, 2025

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T. The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 165
Stock Exchange Egyptian Stock Exchange
Ticker Symbol SIPC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.